Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Antiretroviral drug Lopinavir selectively kills HPV-infected cells in lab tests

The protease inhibitor lopinavir - the primary component of Abbott Laboratories' antiretroviral drug Kaletra - selectively killed the human papillomavirus in laboratory tests, according to a study scheduled to be published next month in the journal Anti-Viral Therapy.

From The University of Manchester 30 Aug 2006

Challenges parents, physicians face in addressing HPV vaccine

The AP/Washington Post on Sunday examined the challenges parents and physicians face in addressing the issues associated with Merck's human papillomavirus vaccine Gardasil (Irvine, AP/Washington Post, 8/27).

30 Aug 2006

History of cervical cancer, HPV vaccine development

The New York Times on Tuesday examined the development of vaccines to prevent transmission of the human papillomavirus, which can cause cervical cancer.

30 Aug 2006

Australian girls lead the field in cervical cancer vaccination programme

Australian females will be one jump ahead of some of their counterparts elsewhere in the world with the first vaccinations against cervical cancer taking place in Brisbane today.

28 Aug 2006

Cervical cancer vaccine tipped for nine year olds

Health experts in the UK are considering vaccinating young girls of primary school age against the human papilloma virus.

28 Aug 2006

Turning the immune system against cancer

Medicine can now prevent a host of diseases with a mere shot of vaccine. Polio and smallpox are almost non-existent, and mumps and chicken pox are rarely seen nowadays.

4 Aug 2006

Most Americans do not know when to get cancer screening tests

While most Americans know that mammograms, pap smears, and colonoscopies are screening exams for cancer, the majority of Americans do not know the appropriate age at which initiation of these tests is recommended.

3 Aug 2006

Human papillomavirus type 16 and 18 variants

Variants of human papillomavirus (HPV) 16 and 18 persist longer in people whose ancestors are from the same geographical area as the virus, according to a study in the August 2 issue of the Journal of the National Cancer Institute.

2 Aug 2006

Doctors say HPV vaccine should be given to everyone

A new vaccine which will protect women against four types of the human papillomavirus (HPV) known to cause cervical cancer will be available within weeks in the UK.

31 Jul 2006

Canada ready to vaccinate against human papillomavirus

Canadian women will soon be able to access the first vaccine to protect against the sexually transmitted virus that causes cervical cancer.

19 Jul 2006

Women who harbor multiple HPV type infections are at higher risk for cervical lesions

The risk for developing the tissue abnormalities, or lesions, that typically precede cervical cancer is much higher for women infected with multiple genotypes of the human papillomavirus (HPV) than previously reported.

10 Jul 2006

CDC recommends human papillomavirus virus vaccination

CDC Advisory Committee Recommends Human Papillomavirus Virus Vaccination Vaccine considered highly effective in preventing infections that are the cause of most cervical cancers.

29 Jun 2006

Vaccine no replacement for Pap test

The Cancer Council Australia cautioned that the vaccine was not a substitute for the Pap screen and that all women aged 18-69 should continue regular two year screening.

27 Jun 2006

New push to tackle priorities in sexual and reproductive health

Leaders of the World Health Organization (WHO) and UNFPA, the United Nations Population Fund, are coordinating action to reverse the global trend of deteriorating levels of sexual and reproductive health and reduce the adverse impact on mothers, babies and young people.

20 Jun 2006

FDA approves cervical cancer vaccine

The Federal Drug Administration (FDA) in the U.S. has recently given its approval for a new vaccine which protects against the human papillomavirus known as HPV.

12 Jun 2006

PATH to pave the way for cervical cancer vaccines in the developing world

The global health nonprofit PATH has launched a five-year effort to make sure that new cervical cancer vaccines - the first vaccines developed and approved just for women's health - reach women in the developing world.

9 Jun 2006

How cow warts, clergy sex surveys moved along cervical cancer vaccine

The creation of a successful vaccine against cervical cancer, approved today by the U.S. Food and Drug Administration, is the culmination of research that occurred thanks not only to scientists and physicians, but also to generous farmers and veterinarians, priests and nuns willing to tell all - and some very patient cows.

9 Jun 2006

New era in cancer prevention

Nearly two decades ago, researchers at the National Cancer Institute (NCI) and other institutions began searching for the underlying causes of cervical cancer.

9 Jun 2006

FDA approves Gardasil as a treatment for cervical cancer

Merck & Co. has announced that the U.S. Food and Drug Administration (FDA) approved Gardasil as a treatment for cervical cancer, vulvar and vaginal pre-cancers caused by HPV types 16 and 18 and to prevent low-grade and pre-cancerous lesions and genital warts caused by HPV types 6, 11, 16 and 18.

9 Jun 2006

FDA approval of Gardasil to prevent cervical cancer

The Food and Drug Administration (FDA) has announced the approval of Gardasil, the first vaccine developed to prevent cervical cancer, precancerous genital lesions and genital warts due to human papillomavirus (HPV) types 6, 11, 16 and 18.

8 Jun 2006